These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2967184)

  • 41. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
    Boberg J; Larsen FF; Pehrsson SK
    Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Slow release nifedipine plus atenolol in chronic stable angina pectoris.
    Challenor VF; Waller DG; Renwick AG; George CF
    Br J Clin Pharmacol; 1989 Nov; 28(5):509-16. PubMed ID: 2511911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris.
    Findlay IN; MacLeod K; Gillen G; Elliott AT; Aitchison T; Dargie HJ
    Br Heart J; 1987 Apr; 57(4):336-43. PubMed ID: 3555566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal control of myocardial ischaemia: the benefit of a fixed combination of atenolol and nifedipine in patients with chronic stable angina.
    el-Tamimi H; Davies GJ
    Br Heart J; 1992 Sep; 68(3):291-5. PubMed ID: 1389761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
    Keyriläinen O; Uustialo A
    Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol.
    Pedersen TR; Kantor M
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):451-6. PubMed ID: 2285629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial.
    Hertzeanu H; Shemesh J; Loidl AF; Kellermann JJ
    Cardiology; 1989; 76(4):312-8. PubMed ID: 2572323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of the effects and safety of atenolol and nifedipine in the treatment of angina pectoris].
    Aschermann M; Bultas J; Danzig V; Mayer O; Lorenc Z; Vortel J; Kvasnicka J
    Vnitr Lek; 1993 Apr; 39(4):345-52. PubMed ID: 8351862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of bisoprolol in coronary heart disease. Effect on cardiovascular parameters and ischemic ST depression: studies on the duration of the effect].
    Prager G; Wagner G
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1914-7. PubMed ID: 6150839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A cross-over study comparing the efficacy of a combination of atenolol and nifedipine at different doses in angina pectoris.
    Metcalfe MJ; Jennings K
    Curr Med Res Opin; 1995; 13(5):251-6. PubMed ID: 7555033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators Group.
    Narahara KA
    Am J Cardiol; 1990 Mar; 65(9):577-82. PubMed ID: 2178381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of bisoprolol on cardiac performance in coronary heart disease.
    Maisch B; Borst U; Gerhards W; Wagner G
    Eur J Clin Pharmacol; 1989; 36(3):217-22. PubMed ID: 2568261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Summary of short- and long-term studies with bisoprolol in coronary heart disease (CHD).
    Wagner G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S160-6. PubMed ID: 2439790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
    Oh PC; Kang WC; Moon J; Park YM; Kim S; Kim MG; Lee K; Ahn T; Shin EK
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
    Quyyumi AA; Wright C; Mockus L; Fox KM
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):951-3. PubMed ID: 6148991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of bevantolol for chronic, stable angina pectoris.
    Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
    Am J Cardiol; 1986 Nov; 58(12):28E-34E. PubMed ID: 2878598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.